VWF and transient ischemic attack: Further limitations include the relatively high proportion of TIA patients (42%) for which a non-vascular origin of symptoms cannot be entirely excluded, and treatment with anticoagulants in 7% of AIS/TIA patients which might interfere with the regulation of VWF levels.